drugset / Trial / NCT04643925

hCG Priming in Women With Low Ovarian Reserve

NCT04643925 ↗

Phase 4 Completed 20 enrolled Rigshospitalet, Denmark
NaSingle-groupOpen-labelTreatment

Summary

The aim of this trial is to examine the possible effects of hCG administration for eight weeks prior to IVF/ICSI in women with low ovarian reserve. Primary outcome is the proportion of the antral follicle count that reach the pre-ovulatory stage.

Timeline

Start
2020-12-27
Primary completion
2021-08-31
Completion
2021-08-31

Outcome

Missed primary endpoint

paper did not increase after 8 weeks of hCG priming (P = 0.8). PMID 36721920 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ovidrel Protein / enzyme biologic 260 iu —